AU2003302000A8 - The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori - Google Patents

The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori

Info

Publication number
AU2003302000A8
AU2003302000A8 AU2003302000A AU2003302000A AU2003302000A8 AU 2003302000 A8 AU2003302000 A8 AU 2003302000A8 AU 2003302000 A AU2003302000 A AU 2003302000A AU 2003302000 A AU2003302000 A AU 2003302000A AU 2003302000 A8 AU2003302000 A8 AU 2003302000A8
Authority
AU
Australia
Prior art keywords
infection
helicobacter pylori
caused
treatment
psoralea corylifolia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302000A
Other versions
AU2003302000A1 (en
Inventor
Chengqi Fan
Lei Dong
Yan Wu
Bingjun Ren
Weiming Fan
Jianmin Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG ZHENYUAN PHARMACEUTIC
Shanghai Institute of Materia Medica of CAS
Original Assignee
ZHEJIANG ZHENYUAN PHARMACEUTIC
Shanghai Institute of Materia Medica of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHEJIANG ZHENYUAN PHARMACEUTIC, Shanghai Institute of Materia Medica of CAS filed Critical ZHEJIANG ZHENYUAN PHARMACEUTIC
Publication of AU2003302000A1 publication Critical patent/AU2003302000A1/en
Publication of AU2003302000A8 publication Critical patent/AU2003302000A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2003302000A 2002-11-21 2003-11-21 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori Abandoned AU2003302000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN02145323.3 2002-11-21
CNB021453233A CN1255124C (en) 2002-11-21 2002-11-21 Application of Psoralca corylifolia in anti-infection of helicobacter pyloric and treating relative diseases
PCT/CN2003/000988 WO2004045631A1 (en) 2002-11-21 2003-11-21 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori

Publications (2)

Publication Number Publication Date
AU2003302000A1 AU2003302000A1 (en) 2004-06-15
AU2003302000A8 true AU2003302000A8 (en) 2004-06-15

Family

ID=32315215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302000A Abandoned AU2003302000A1 (en) 2002-11-21 2003-11-21 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori

Country Status (3)

Country Link
CN (1) CN1255124C (en)
AU (1) AU2003302000A1 (en)
WO (1) WO2004045631A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101229223B (en) * 2008-02-03 2011-09-14 中国科学院化学研究所 Applications of fructus psoraleae extractive on preparing antitumor medicines
CN112451540B (en) * 2020-11-25 2022-03-01 华熙生物科技股份有限公司 Hyaluronic acid with anti-helicobacter pylori digestive tract infection activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054747C (en) * 1994-02-05 2000-07-26 马新生 Anti-cancer capsule
CN1126605A (en) * 1995-06-21 1996-07-17 毕盛 Shenglianhuishengdan pellet and its prepn
CN1084206C (en) * 1999-05-20 2002-05-08 周金龙 Cancer treating medicine and its preparation
CN1446814A (en) * 2003-03-07 2003-10-08 上海大学 Method for preparing psoralen and isopsoralen

Also Published As

Publication number Publication date
WO2004045631A1 (en) 2004-06-03
CN1502346A (en) 2004-06-09
AU2003302000A1 (en) 2004-06-15
CN1255124C (en) 2006-05-10

Similar Documents

Publication Publication Date Title
AU2003270903A8 (en) A video game for assisting healing of the human body
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
CY2014019I1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
IL166150A0 (en) Apparatus for altering the body temperature of a patient
PL377122A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
HK1068559A1 (en) Implement for assisting inflation of medical implement with cuff; and bronchus closing implement with the implement
IL157149A0 (en) Phenethanolamine derivatives for treatment of respiratory diseases
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
GB0514417D0 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
GB0004531D0 (en) The treatment of respiratory diseases
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003302000A8 (en) The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori
NO20055137D0 (en) Combination of a macrolide and a local anesthetic for the treatment of skin diseases
FI20021617A0 (en) Diagnostic and therapeutic procedures
NO20031656D0 (en) Combination comprising camptothecin and a still bone derivative for the treatment of cancer
IL164826A0 (en) Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor
AU2003274649A8 (en) Diagnostic markers for therapeutic treatment
GB2390312B (en) Apparatus for therapeutically exercising parts of the human body
EP1453468A4 (en) Method of vaccinating a human patient to prevent metastatic tumors
GB0220560D0 (en) Apparatus for therapeutically exercising parts of the human body
AU2002365654A8 (en) Treatment of diseases via the skin
TW519898U (en) Improved structure of vagina dilator
GB0129817D0 (en) The treatment of pre-term labour

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 27, PAGE(S) 7457 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, APPLICATION NO. 2003302000, UNDER INID (71) CORRECT THE NAME TO READ ZHEJIANG ZHENYUAN PHARMACEUTICAL CO., LTD.; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase